Milestone Pharmaceuticals Inc.
MIST · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $25 | $0 | $0 | $567 |
| Gross Profit | -$25 | $0 | $0 | -$567 |
| % Margin | – | – | – | – |
| R&D Expenses | $4,013 | $3,669 | $4,978 | $4,005 |
| G&A Expenses | $0 | $3,759 | $5,167 | $0 |
| SG&A Expenses | $7,864 | $8,862 | $15,545 | $7,841 |
| Sales & Mktg Exp. | $0 | $5,103 | $10,378 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $11,877 | $12,531 | $20,523 | $11,846 |
| Operating Income | -$11,902 | -$12,531 | -$20,523 | -$12,413 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$93 | -$435 | -$238 | -$15 |
| Pre-Tax Income | -$11,995 | -$12,966 | -$20,761 | -$12,428 |
| Tax Expense | -$73 | $0 | $0 | -$65 |
| Net Income | -$11,922 | -$12,966 | -$20,761 | -$12,363 |
| % Margin | – | – | – | – |
| EPS | -0.12 | -0.2 | -0.31 | -0.2 |
| % Growth | 40% | 35.5% | -55% | – |
| EPS Diluted | -0.12 | -0.2 | -0.31 | -0.2 |
| Weighted Avg Shares Out | 66,380 | 66,380 | 66,285 | 62,211 |
| Weighted Avg Shares Out Dil | 66,380 | 66,380 | 66,285 | 62,211 |
| Supplemental Information | – | – | – | – |
| Interest Income | $874 | $516 | $697 | $904 |
| Interest Expense | $967 | $951 | $935 | $919 |
| Depreciation & Amortization | $25 | $28 | $27 | $567 |
| EBITDA | -$11,003 | -$11,987 | -$19,799 | -$10,942 |
| % Margin | – | – | – | – |